Form 4: Paychex Inc. Executive Sells Shares and Reports Stock Option Holdings
SEC Filing Form 4
Mark Anthony Bottini, a Senior VP at Paychex Inc., reported the sale of 8,954 shares of common stock at $123.60 and disclosed holdings of various stock options.
Summary
- On July 24, 2024, Mark Anthony Bottini, a Senior Vice President of Sales at Paychex Inc. (PAYX), filed a Form 4 with the SEC.
- The form details a transaction where Bottini sold 8,954 shares of Paychex common stock at a price of $123.60 per share.
- Following the transaction, Bottini directly owns 79,232 shares of Paychex common stock.
- Bottini also indirectly owns 1,668 shares through a 401(k) and 23 shares through an ESPP.
- The filing also discloses Bottini's holdings of multiple stock options with varying exercise prices and expiration dates, totaling 434,452 options.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard SEC filing reporting a stock sale by an executive. It doesn't inherently indicate positive or negative sentiment about the company's future.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.
Comparison to Industry Standards
- Executive stock sales are common, and the impact on the stock price depends on the size of the sale relative to the executive's holdings and the overall trading volume of the stock.
- Comparable companies like ADP and Ceridian also have executives who regularly file Form 4s.
- The details of stock option grants and vesting schedules are typically outlined in the company's proxy statements.
Stakeholder Impact
- The sale of shares by a company executive can sometimes be perceived negatively by shareholders, although routine sales are common.
- The filing provides transparency to stakeholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 07/08/2016 | Date exercisable for stock options with an exercise price of $47.32 and expiration date of 07/07/2025. |
| 07/06/2017 | Date exercisable for stock options with an exercise price of $60.84 and expiration date of 07/05/2026. |
| 07/12/2018 | Date exercisable for stock options with an exercise price of $57.24 and expiration date of 07/11/2027. |
| 07/11/2019 | Date exercisable for stock options with an exercise price of $69.54 and expiration date of 07/10/2028. |
| 07/10/2020 | Date exercisable for stock options with an exercise price of $85.46 and expiration date of 07/09/2029. |
| 07/15/2021 | Date exercisable for stock options with an exercise price of $73.53 and expiration date of 07/14/2030. |
| 07/15/2022 | Date exercisable for stock options with an exercise price of $112.67 and expiration date of 07/14/2031. |
| 07/15/2023 | Date exercisable for stock options with an exercise price of $115 and expiration date of 07/14/2032. |
| 07/15/2024 | Date exercisable for stock options with an exercise price of $120.86 and expiration date of 07/14/2033. |
| 07/24/2024 | Date of the reported transaction: sale of 8,954 shares of common stock. |
| 07/25/2024 | Date of the form filing. |
| 07/15/2025 | Date exercisable for stock options with an exercise price of $121.63 and expiration date of 07/14/2034. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.